Grafa News and Videos — Page 12

GE HealthCare (NASDAQ:GEHC) executed a definitive agreement to acquire SOFIE Biosciences from Trilantic North America for a cash purchase price of $945 million.

Alector (NASDAQ:ALEC) executed an exclusive global licensing agreement with Genentech for AL050, an investigational enzyme replacement therapy targeting Parkinson’s disease.

Harrow (NASDAQ:HROW) closed the acquisition of TYRVAYA from Viatris to expand its commercial ophthalmic portfolio with an approved dry eye treatment.

Rezolute (NASDAQ:RZLT) announced that the U.S. Food and Drug Administration recommended a pre-BLA meeting prior to any potential biologics license application for ersodetug.

Stoke Therapeutics (NASDAQ:STOK) announced the successful completion of a meeting with the U.S. Food and Drug Administration regarding its investigational zorevunersen treatment.

C.H. Robinson (NASDAQ:CHRW) agreed to acquire RXO (NYSE:RXO) in a $5.8 billion stock-and-cash transaction.

Summit Therapeutics (NASDAQ:SMMT) completed a $2 billion strategic equity investment from AstraZeneca (NASDAQ:AZN) to advance its clinical oncology pipeline.

The GEO Group (NYSE:GEO) completed the $950 million sale of three California processing centers to the Department of Homeland Security.

ECARX (NASDAQ:ECX) acquired the Flyme software business portfolio for RMB 1.8 billion to bring operating systems in-house.

Advanced Drainage Systems (NYSE:WMS) executed a definitive agreement to acquire StormTrap Investments for approximately $530 million.